Tomi Streng

Dr. Tomi Streng


Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 February 2010 in BJU International
Verified
Journal Article
Closed access
PDF file
TSTomi Streng
Tomi Streng
RSRisto Santti
Risto Santti
KAKarl‐Erik Andersson
Karl‐Erik Andersson

31 January 2022 in Veterinary Sciences
Verified
Journal Article
Open access
PDF file
RSRisto Santti
Risto Santti
EYEmrah Yatkin
Emrah Yatkin
JBJenni Bernoulli
Jenni Bernoulli
TSTomi Streng
Tomi Streng
The prevalence of LUTS and prostatic diseases increases with age both in humans and companion animals, suggesting that a common underlying cause of these conditions may be age-associated alterations in the balance of sex hormones. The symptoms are present with different and variable micturition dysfunctions and can be assigned to different clinical conditions including bladder outlet obstruction (BOO). LUTS may also be linked to chronic non-bacterial prostatitis/chronic pelvic pain syndrome (CP/CPPS), but the relationship between these conditions is unknown. This review summarizes the preclinical data that supports a role for excessive estrogen action in the development of obstructive voiding and nonbacterial prostatic inflammation. Preclinical studies that are emphasized in this review have unequivocally indicated that estrogens can induce functional and structural changes resembling those seen in human diseases. Recognizing excessive estrogen action as a possible hormonal basis for the effects observed at multiple sites in the LUT may inspire the development of innovative treatment options for human and animal patients with LUTS associated with functional BOO and CP/CPPS.